Results 151 to 160 of about 41,188 (289)
Low Dose Splenic Radiotherapy for Myeloproliferative Neoplasms prior to Allogeneic Hematopoietic Stem Cell Transplant [PDF]
, 2023 Claire Baniel +6 more
openalex +1 more source
Cancer Reports, Volume 9, Issue 1, January 2026.ABSTRACT Background Hematopoietic stem cell transplantation (HSCT) is associated with significant morbidity and mortality. Frailty further increases these risks in recipients of HSCT. This systematic review analyzes the extent of frailty in patients with hematologic malignancies and patients undergoing HSCT, and explores the associations between ...
Marit Bakken +4 more
wiley +1 more source
How we manage Philadelphia‐negative myeloproliferative neoplasms in pregnancy [PDF]
, 2020 Susan Robinson, Claire Harrison
openalex +1 more source
Clinical Pharmacology &Therapeutics, Volume 119, Issue 1, Page 219-227, January 2026.Pegbing® (peginterferon alfa‐2b), a pegylated interferon‐alpha, is approved for the treatment of chronic hepatitis B (CHB) and C. One of its adverse effects is platelet (PLT) suppression. It is currently being repurposed for the treatment of essential thrombocythemia (ET), a rare myeloproliferative disorder characterized by abnormally elevated PLT ...
Weizhe Jian +7 more
wiley +1 more source
Clinical impact of atrial fibrillation on hospitalized patients with myeloproliferative neoplasms: A nationwide analysis [PDF]
Samhitha Gundakaram +4 more
openalex +1 more source
JAK2 p.V617F detection and allele burden measurement in peripheral blood and bone marrow aspirates in patients with myeloproliferative neoplasms [PDF]
, 2013 Koichi Takahashi +6 more
openalex +1 more source
Cell competition between wild-type and JAK2V617F mutant cells prevents disease relapse after stem cell transplantation in a murine model of myeloproliferative neoplasm [PDF]
, 2021 Haotian Zhang +3 more
openalex +1 more source